Scrip
US FDA warns Sanofi-Aventis over misleading Uroxatral promotion
30 October 2009
Nancy Faigen
The
US FDA has warned
Sanofi-Aventis that a promotional item known as a tent card for its alpha(1)-blocker Uroxatral (alfuzosin extended-release tablets) is misleading because the front side presents effectiveness claims but omits "
any risk information associated with its use". Indication...
Please Login to read the full article.
30 October 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
